VESANOID 10mg - Tretinoin (ATRA) by Roche

    VESANOID

    10mg
    Oncology Medications

    VESANOID10mg

    VESANOID (Tretinoin/ATRA) 10mg capsules by Roche — differentiation therapy for acute promyelocytic leukemia (APL). ATRA+ATO: 97% CR, 90%+ cure rate.

    Generic Name:Tretinoin (ATRA)
    Manufacturer:Roche

    Key Benefits

    • 97% complete remission with ATRA+ATO protocol
    • 90%+ long-term cure rate — most curable AML subtype
    • Differentiation therapy — unique mechanism of action
    • Oral capsules — convenient administration
    • Room temperature storage — no cold chain needed
    • Emergency supply available for urgent APL cases

    Contact Us for Pricing

    Get competitive wholesale pricing for VESANOID 10mg. Our team is available 24/7.

    Direct line: +44 7429 917553

    Licensed Supplier

    Authorized pharmaceutical distributor

    100% Original

    Guaranteed authentic products

    Worldwide Delivery

    International shipping available

    24/7 Support

    WhatsApp support anytime

    How VESANOID Works

    1

    Tretinoin (ATRA) induces terminal differentiation of leukemic promyelocytes by degrading the PML-RARα fusion oncoprotein caused by t(15;17) translocation. This releases the block on myeloid differentiation, forcing immature cancer cells to mature into functional granulocytes.

    About VESANOID 10mg

    VESANOID (Tretinoin/All-Trans Retinoic Acid) 10mg capsules by Roche is the revolutionary differentiation therapy that transformed acute promyelocytic leukemia (APL) from 75% fatal to 90%+ curable. Unlike conventional chemotherapy, ATRA forces leukemic promyelocytes to differentiate into mature granulocytes by degrading the PML-RARα fusion oncoprotein. The ATRA+ATO (arsenic trioxide) protocol achieves 97% complete remission and 99% overall survival at 50 months — making APL the most curable form of acute myeloid leukemia, without conventional chemotherapy. As a licensed pharmaceutical supplier, we maintain emergency stock of Vesanoid for urgent APL supply with express shipping worldwide.

    Common Uses

    • Acute promyelocytic leukemia (APL/AML-M3) — induction therapy
    • APL with t(15;17) translocation / PML-RARα fusion
    • ATRA+ATO protocol (low/intermediate-risk APL)
    • ATRA+chemotherapy (high-risk APL)

    Dosage Information

    Adults: 45mg/m²/day orally in 2 divided doses. Children: 25mg/m²/day. Continue until CR or maximum 90 days. Take with food.

    Always consult with a qualified healthcare professional for proper dosing. This information is for reference only.

    Storage & Handling

    Store at 15-25°C (59-77°F). Protect from light and heat. Keep in original packaging. No refrigeration required.

    We ensure proper cold chain handling during shipping to maintain product integrity.

    Frequently Asked Questions About VESANOID

    Find answers to common questions about ordering, pricing, and shipping.

    Ready to Order VESANOID?

    Contact our team via WhatsApp for instant quotes, availability, and shipping information.

    Related Oncology Medications Products

    Explore more oncology medications medications from our catalog

    ABRAXANE 100mg - Paclitaxel
    Oncology Medications

    ABRAXANE100mg

    Paclitaxel

    Bristol Myers
    AFINITOR 10mg - Everolimus
    Oncology Medications

    AFINITOR10mg

    Everolimus

    Novartis
    ALECENSA  - Alectinib
    Oncology Medications

    ALECENSA

    Alectinib

    Roche
    ALTUZAN 400mg - Bevacizumab
    Oncology Medications

    ALTUZAN400mg

    Bevacizumab

    Roche